StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.54+0.30 (+2.27%)

Close on Nov 16, 2026Market cap $250.17MP/E –Yield –

USANA Health Sciences total assets

Total assets on the balance sheet at the end of each period.

USANA Health Sciences's total assets was $708.47M at Oct 3, 2026. For fiscal 2025 it was $742.92M, down 0.7% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $748.19M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Jan 3, 2026$742.92M-0.7%
FY2024Dec 28, 2024$748.19M+18.2%
FY2023Dec 30, 2023$632.76M+6.1%
FY2022Dec 31, 2022$596.55M+3.3%
FY2021Jan 1, 2022$577.74M-9.9%
FY2020Jan 2, 2021$640.89M+24.0%
FY2019Dec 28, 2019$516.93M-6.8%
FY2018Dec 29, 2018$554.46M+6.8%
FY2017Dec 30, 2017$519.27M+10.3%
FY2016Dec 31, 2016$470.64M+11.2%
FY2015Jan 2, 2016$423.24M+20.7%
FY2014Jan 3, 2015$350.58M-4.9%
FY2013Dec 28, 2013$368.47M+37.8%
FY2012Dec 29, 2012$267.36M+9.3%
FY2011Dec 31, 2011$244.50M+12.9%
FY2010Jan 1, 2011$216.64M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Oct 3, 2026$708.47M-2.5%
Q2 FY2026Jul 4, 2026$703.21M-4.3%
Q1 FY2026Apr 4, 2026$738.97M-1.0%
Q4 FY2025Jan 3, 2026$742.92M-0.7%
Q3 FY2025Sep 27, 2025$726.59M+8.2%
Q2 FY2025Jun 28, 2025$734.53M+16.3%
Q1 FY2025Mar 29, 2025$746.60M+18.6%
Q4 FY2024Dec 28, 2024$748.19M+18.2%
Q3 FY2024Sep 28, 2024$671.31M+11.7%
Q2 FY2024Jun 29, 2024$631.42M+4.8%
Q1 FY2024Mar 30, 2024$629.28M+3.9%
Q4 FY2023Dec 30, 2023$632.76M+6.1%
Q3 FY2023Sep 30, 2023$601.15M+8.1%
Q2 FY2023Jul 1, 2023$602.68M+8.0%
Q1 FY2023Apr 1, 2023$605.53M+5.7%
Q4 FY2022Dec 31, 2022$596.55M+3.3%
Q3 FY2022Oct 1, 2022$556.06M-4.0%
Q2 FY2022Jul 2, 2022$557.96M-5.7%
Q1 FY2022Apr 2, 2022$572.92M-2.0%
Q4 FY2021Jan 1, 2022$577.74M-9.9%
Q3 FY2021Oct 2, 2021$578.95M+0.2%
Q2 FY2021Jul 3, 2021$591.45M+15.5%
Q1 FY2021Apr 3, 2021$584.51M+23.4%
Q4 FY2020Jan 2, 2021$640.89M+24.0%
Q3 FY2020Sep 26, 2020$577.53M+24.7%
Q2 FY2020Jun 27, 2020$512.15M-3.8%
Q1 FY2020Mar 28, 2020$473.75M-14.1%
Q4 FY2019Dec 28, 2019$516.93M-6.8%
Q3 FY2019Sep 28, 2019$463.04M-22.7%
Q2 FY2019Jun 29, 2019$532.40M-7.5%
Q1 FY2019Mar 30, 2019$551.58M+1.0%
Q4 FY2018Dec 29, 2018$554.46M+6.8%
Q3 FY2018Sep 29, 2018$599.38M+22.2%
Q2 FY2018Jun 30, 2018$575.28M+9.6%
Q1 FY2018Mar 31, 2018$545.95M+15.7%
Q4 FY2017Dec 30, 2017$519.27M+10.3%
Q3 FY2017Sep 30, 2017$490.65M–
Q2 FY2017Jul 1, 2017$524.78M–
Q1 FY2017Apr 1, 2017$472.01M–
Q4 FY2016Dec 31, 2016$470.64M–

More USANA Health Sciences figures

See a number that looks wrong?